Tegonat 15 (Tegafur/Gimeracil/Oteracil)

Summary

Tegonat 15 is a chemotherapy drug that contains Tegafur, Gimeracil, and Oteracil, which is a treatment for different types of cancer, including gastric (stomach) cancer as well as colorectal cancer. The drug is part of the category of antimetabolite drugs that function by interfering with the synthesis of DNA in cancer cells. This inhibits the growth of and increases in. Tegafur is a prodrug for 5-fluorouracil (5-FU), known as an anticancer drug. Gimeracil increases the effectiveness of Tegafur by preventing 5FU’s breakdown, and Oteracil assists in reducing toxicity to the gastrointestinal tract by preventing activation of 5-FU within the digestive tract. The combination increases the effectiveness of anticancer drugs and reduces the risk of adverse side effects.

What is Tegonat 15?

Tegonat 15 is an oral anticancer medicine that consists of three active ingredients:

• Tegafur: A prodrug that is converted to 5-fluorouracil (5-FU) inside the body. It hinders DNA synthesis within cancer cells, stopping the replication of their DNA.
• Gimeracil: It is an inhibitor of dihydropyrimidine dehydrogenase (DPD), the enzyme that is responsible for breaking down 5-FU, which prolongs and enhances the therapeutic effect.
• Oteracil: A substance that decreases 5-FU’s activities in the digestive tract, thus reducing the risk of GI adverse effects like mucositis and diarrhea.

Together, these elements make for more effective and comfortable chemotherapy when compared with traditional 5-FU treatment.

Indications and Uses

Tegonat 15 is recommended to treat:

• Gastric (Stomach) Cancer: For adjuvant treatment post-surgery, or in advanced stages.
• Colorectal Cancer: As well as for metastatic advanced disease and adjuvant treatments.
• Other Solid Tumors: Sometimes, other cancers are susceptible to 5-FU-based chemotherapy according to the advice of an oncologist.

Mechanism of Action

• Tegafur is taken orally and is converted into 5-FU. It is then incorporated into DNA and RNA from cancer cells, disabling the function of cancer cells.
• Gimeracil blocks the enzyme DPD, which slows the degradation of 5-FU, increasing the plasma concentration and increasing the effectiveness of chemotherapy.
• Oteracil restricts the activity (activation) of 5-FU within the intestinal tract and protects healthy cells of the gut lining from injury.

The three-step mechanism provides prolonged anticancer effects with less toxic effects on the gastrointestinal tract.

Dosage and Administration

General Guidelines:

• Tegonat 15 is administered orally.
• The dosage schedule is determined by the kind of cancer, the stage, the patient’s health, as well as treatment procedure.
• They are usually taken two times a day after eating with water in order to increase digestion and decrease the feeling of nausea.

Typical Dose:

• The daily dose is usually between 40 mg and 60 mg/m² and is divided into two doses.
• The typical treatment cycle lasts 4 weeks. They are followed by 2 weeks of rest, although this could be different.
• The dosage and duration are determined by an oncologist.

Special Considerations:

• Adjustments to dosages may be required for patients suffering from impaired liver or kidney function.
• Monitoring of blood counts as well as liver/kidney function is essential in the course of the treatment.

Side Effects

Similar to many chemotherapy medications, Tegonat 15 may cause side effects as a result of its actions on cells that are rapidly growing cells.

Common Side Effects:

• Nausea and vomiting
• Diarrhea
• Loss of appetite
• Fatigue and weakness
• Mouth sores (stomatitis)
• Hand-foot syndrome (redness, swelling, pain on palms and soles)
• Mild anemia or low blood counts (neutropenia, thrombocytopenia)

Serious Side Effects:

• Severe neutropenia (low white blood cell count), increasing infection risk
• Severe diarrhea leading to dehydration
• Liver toxicity (elevated liver enzymes)
• Allergic reactions (rash, itching, swelling)
• Cardiovascular issues (rare but possible)

Patients are required to report any unusual or unusual symptoms as soon as they occur to their physician.

Precautions and Warnings

• Pregnancy and Breastfeeding: Tegonat 15 is contraindicated in pregnancy due to the teratogenic effect and should not be used for use during lactation.
• Blood Disorders: Monitoring blood count regularly is vital; treatments could need to be stopped or the dosage reduced.
• Kidney and Liver Impairment: A little caution is advised; dosage adjustments may be needed.
• Drug Interactions: Tell your doctor about any medication, particularly the use of anticoagulants, chemotherapeutics, or antifungal drugs.
• Allergies: Be sure to report any allergy history to fluoropyrimidine medications.

Storage Instructions

• Place in a cool and dry location, shielded from the sun’s rays.
• Store the medicine in the original container until the time of use.
• Keep at room temperature generally between 20°C and 25°C (68°F to 77°F).
• Stay out of the reach of children and pets.
• Use only until the date of expiration.

How to Take Tegonat 15

• Consume the capsules along with a full glass of water immediately after eating.
• Don’t crush or chew capsules.
• Be sure to follow the schedule as it is prescribed.
• Do not miss doses. If you missed a dose, do it as soon as you can remember it, or until the time to take your next dose.
• Make sure you schedule regular follow-up appointments to conduct blood tests as well as the clinical examination.

Frequently Asked Questions (FAQs)

Q1: What cancers can Tegonat 15 treat?

A: It’s mostly utilized for colorectal and gastric cancers. However, it can also be utilized to treat other tumors that are responsive to chemotherapy using 5-FU.

Q2: How does Tegonat 15 differ from traditional chemotherapy?

A: Tegonat is a combination of Tegafur (a drug that is a prodrug for 5-FU) along with Gimeracil as well as Oteracil to increase efficacy as well as lessen gastrointestinal side effects when compared with intravenous 5-FU.

Q3: Can I take Tegonat 15 if I have liver or kidney problems?

A: Inform your doctor if you suffer from problems with your kidneys or liver. Alternate treatments or dosage adjustments may be required.

Q4: What should I do if I experience severe diarrhea or mouth sores?

A: Make contact with your physician promptly. The side effects could be severe and need treatment adjustments.

Q5: Is Tegonat 15 safe during pregnancy?

A: No. This medication is not recommended in pregnancy because of the risk of birth problems.

Q6: How is the medication supplied?

A: Most commonly, they are 15 mg capsules, although the strength could vary based on the maker. Be sure to confirm dosage with your physician.

Q7: How long does treatment with Tegonat 15 last?

A: The duration of treatment varies based on the type of cancer or stage, as well as the reaction. Most often, it is offered in cycles and with rest times between. The oncologist you consult with will provide advice.

Q8: Are there any dietary restrictions while taking Tegonat 15?

A: Not a lot of restrictions, but it is vital to maintain a balanced diet. Do not drink alcohol and speak with your doctor about any supplementation.

Q9: Can I drive or operate machinery while on Tegonat 15?

A: The symptoms of dizziness and fatigue may be present. Beware of driving and operating large machines until you are aware of what the effects of the medication are.

Q10: What should I do if I miss a dose?

A: You should take the dose missed immediately after you recall it or unless you are nearing the due time for your next dose. Don’t double doses.

Conclusion

Tegonat 15 (Tegafur/Gimeracil/Oteracil) offers an effective oral chemotherapy option for patients with gastric and colorectal cancers, combining enhanced therapeutic action with reduced gastrointestinal toxicity. Strict medical supervision and surveillance for any side effects are crucial to the success of treatment. Follow the instructions of your doctor and inform them of any adverse reactions promptly.